Necrosulfonamide Ameliorates Neurological Impairment in Spinal Cord Injury by Improving Antioxidative Capacity
Currently, there is no efficient therapy for spinal cord injury (SCI). Anoxemia after SCI is a key problem, which leads to tissue destruction, while hypoxia after SCI induces cell injury along with inflammation. Mixed-lineage kinase domain-like protein (MLKL) is a critical signal molecule of necropt...
Main Authors: | Jianhang Jiao, Yang Wang, Pengfei Ren, Shicai Sun, Minfei Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.01538/full |
Similar Items
-
MCC950, a Selective Inhibitor of NLRP3 Inflammasome, Reduces the Inflammatory Response and Improves Neurological Outcomes in Mice Model of Spinal Cord Injury
by: Jianhang Jiao, et al.
Published: (2020-03-01) -
Does surgical treatment within 4 hours after trauma have an influence on neurological remission in patients with acute spinal cord injury?
by: Biglari B, et al.
Published: (2016-08-01) -
RIP3 inhibition protects locomotion function through ameliorating mitochondrial antioxidative capacity after spinal cord injury
by: Yang Wang, et al.
Published: (2019-08-01) -
Pressure ulcers in individuals with spinal cord injury: risk factors in neurological rehabilitation
by: Janaina Barbosa da Silva, et al.
Published: (2020-08-01) -
Intramedullary spinal cord abscess presentation which is mimicking spinal tumor: A rare case
by: Tevfik Yılmaz, et al.
Published: (2014-03-01)